Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |